Literature DB >> 11215745

Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C.

C Herold, P Berg, D Kupfal, D Becker, D Schuppan, E G Hahn, H T Schneider.   

Abstract

Our aim was to compare color-coded Doppler sonography (CCDS) and quantitative testing of liver function (QTLF) in patients with chronic hepatitis C. In all, 74 patients with chronic hepatitis C and mild fibrosis underwent QTLF, which included aminopyrine breath test (ABT), galactose elimination capacity (GEC), sorbitol clearance (SC), and indocyanine green clearance (ICG). Hepatic artery velocity and resistance index (HA-V, HA-RI) as well as portal vein velocity (PV-V) were measured by CCDS. ABT, GEC, and PV-V were significantly reduced, whereas SC1, ICG, HA-V, and HA-RI showed normal levels. There was a significant correlation between reduction in PV-V only with GEC and ABT. QTLF did not correlate with HA-V and HA-RI. In conclusion, in hepatitis C patients with liver fibrosis, ABT and GEC are decreased significantly, which was paralleled by a reduction of PV-V. Unexpectedly SC1 and ICG, the classical hepatic perfusion parameters, do not correlate with the parameters measured by CCDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11215745     DOI: 10.1023/a:1026600921967

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Estimation of total hepatic blood flow by duplex ultrasound.

Authors:  K M Carlisle; M Halliwell; A E Read; P N Wells
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

Review 2.  Accuracy and reproducibility of portal flow measurement by Doppler US.

Authors:  L Bolondi; S Gaiani; L Barbara
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  Use of Doppler sonography for revealing hepatic artery stenosis in liver transplant recipients.

Authors:  J F Platt; G G Yutzy; R O Bude; J H Ellis; J M Rubin
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

4.  Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.

Authors:  J Zeeh; H Lange; J Bosch; S Pohl; H Loesgen; R Eggers; M Navasa; J Chesta; J Bircher
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

5.  Prognostic evaluation in alcoholic cirrhosis.

Authors:  N Tygstrup; P K Andersen; B L Thomsen
Journal:  Acta Med Scand Suppl       Date:  1985

6.  Short report: interferon-alpha decreases 14C-aminopyrine breath test values in patients with chronic hepatitis C.

Authors:  Y Horsmans; R Brenard; A P Geubel
Journal:  Aliment Pharmacol Ther       Date:  1994-06       Impact factor: 8.171

7.  Determination of the hepatic elimination capacity (Lm) of galactose by single injection.

Authors:  N Tygstrup
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966

8.  Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.

Authors:  M Bolognesi; D Sacerdoti; C Merkel; G Gerunda; A Maffei-Faccioli; P Angeli; R M Jemmolo; G Bombonato; A Gatta
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

9.  Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability.

Authors:  A Cavanna; G Molino; M Ballarè; M Torchio; M Fracchia; P Avagnina; J Bircher
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

10.  Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.

Authors:  J F Schneider; A L Baker; N W Haines; G Hatfield; J L Boyer
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

View more
  6 in total

1.  Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C.

Authors:  A K P Lim; S D Taylor-Robinson; N Patel; R J Eckersley; R D Goldin; G Hamilton; G R Foster; H C Thomas; D O Cosgrove; M J K Blomley
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study.

Authors:  M J K Blomley; A K P Lim; C J Harvey; N Patel; R J Eckersley; R Basilico; R Heckemann; A Urbank; D O Cosgrove; S D Taylor-Robinson
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

4.  Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Authors:  Christoph Herold; Sabine Regn; Marion Ganslmayer; Matthias Ocker; Eckhart G Hahn; Detlef Schuppan
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

5.  Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.

Authors:  Michael Sørensen; Ole Lajord Munk; Frank Viborg Mortensen; Aage Kristian Olsen; Dirk Bender; Ludvik Bass; Susanne Keiding
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-15       Impact factor: 4.052

6.  Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.

Authors:  M Miller; A Kahraman; B Ross; M Beste; Guido Gerken
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.